Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.
Simon-Molas H, Arnedo-Pac C, Fontova P, Vidal-Alabró A, Castaño E, Rodríguez-García A, Navarro-Sabaté À, Lloberas N, Manzano A, Bartrons R. Simon-Molas H, et al. Mol Cell Biochem. 2018 Nov;448(1-2):187-197. doi: 10.1007/s11010-018-3325-9. Epub 2018 Feb 12. Mol Cell Biochem. 2018. PMID: 29435871
Akt mediates TIGAR induction in HeLa cells following PFKFB3 inhibition.
Simon-Molas H, Calvo-Vidal MN, Castaño E, Rodríguez-García A, Navarro-Sabaté À, Bartrons R, Manzano A. Simon-Molas H, et al. FEBS Lett. 2016 Sep;590(17):2915-26. doi: 10.1002/1873-3468.12338. Epub 2016 Aug 24. FEBS Lett. 2016. PMID: 27491040 Free article.
The potential utility of PFKFB3 as a therapeutic target.
Bartrons R, Rodríguez-García A, Simon-Molas H, Castaño E, Manzano A, Navarro-Sabaté À. Bartrons R, et al. Expert Opin Ther Targets. 2018 Aug;22(8):659-674. doi: 10.1080/14728222.2018.1498082. Epub 2018 Jul 16. Expert Opin Ther Targets. 2018. PMID: 29985086 Review.
Fructose 2,6-Bisphosphate in Cancer Cell Metabolism.
Bartrons R, Simon-Molas H, Rodríguez-García A, Castaño E, Navarro-Sabaté À, Manzano A, Martinez-Outschoorn UE. Bartrons R, et al. Front Oncol. 2018 Sep 4;8:331. doi: 10.3389/fonc.2018.00331. eCollection 2018. Front Oncol. 2018. PMID: 30234009 Free PMC article. Review.
ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma.
Bachiller M, Barceló-Genestar N, Rodriguez-Garcia A, Alserawan L, Dobaño-López C, Giménez-Alejandre M, Castellsagué J, Colell S, Otero-Mateo M, Antoñana-Vildosola A, Español-Rego M, Ferruz N, Pascal M, Martín-Antonio B, Anguela XM, Fillat C, Olesti E, Calvo G, Juan M, Delgado J, Pérez-Galán P, Urbano-Ispizua Á, Guedan S. Bachiller M, et al. Among authors: rodriguez garcia a. Mol Ther. 2024 Nov 19:S1525-0016(24)00755-X. doi: 10.1016/j.ymthe.2024.11.028. Online ahead of print. Mol Ther. 2024. PMID: 39563035 Free article.
Validation of the Zarit Burden Interview in Informal Caregivers of Patients with Severe Visual Impairment and Blindness.
Ruiz-Lozano RE, Herrera-Rodriguez MI, Mendoza-Pallares JA, Reyes-Godinez N, Tamez-Tamez VE, Ramos-Dávila EM, Villagomez-Valdez LG, Garza-Garza LA, Quiroga-Garza ME, Khodor A, Gongora-Cortes JJ, Rodriguez-Garcia A. Ruiz-Lozano RE, et al. Among authors: rodriguez garcia a. Ophthalmol Ther. 2024 Nov 2. doi: 10.1007/s40123-024-01050-6. Online ahead of print. Ophthalmol Ther. 2024. PMID: 39487930
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice.
Branford JA, Bodaghi B, Ferreira LB, McCluskey PJ, Thorne JE, Matthews JM; International Study Group for Systemic Immunomodulatory Drug Treatment of Non‐Infectious Uveitis; Smith JR. Branford JA, et al. Br J Ophthalmol. 2024 Nov 1:bjo-2024-326239. doi: 10.1136/bjo-2024-326239. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39472042
264 results